RankAlpha logo
Back to Rankings

MDXG

MiMedx GroupA
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart

Operating peers and competitors

Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.

Loading market evidence...

Research comparisons do not establish forecast usefulness or trading returns.

Compare shared product markets

Membership only; no portfolio weights or estimated losses.

+
Peers tracked
8
U.S. public peers
Grade Position
Above peers
vs peer average
MDXG vs peer average
80/100
MDXG vs. peer average (A vs. C)
Grade spread
A 1 · B 2 · C 3 · D 1 · F 1
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

IRWD is the first available peer comparator.

Similar packet market capitalization and sector classification, but its pharmaceutical business is not a demonstrated direct operating comparable; do not use as a firm valuation anchor.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerIRWDIronwood
MDXG
MiMedx Group
IRWD
Ironwood
Grade
A
B
Momentum
53
22
Value
64
71
Sentiment
63
51
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Constructive

Grade position vs IRWD

MDXG / IRWD
Grade Position
Above peers
MDXG vs. peer average (A vs. C)
80/100
Momentum
53
MDXG
Value
64
IRWD
Sentiment
63
MDXG

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs MDXG
1
IRWD
IRWD
B
80/100
-1
2
MYGN
MYGN
F
20/100
-4
3
PBYI
Puma Biotechnology Inc Common
C
60/100
-2
4
ACRS
Aclaris Therapeutics Inc Common
C
60/100
-2
5
ZVRA
Zevra Therapeutics Inc Common
A
100/100
Even
IRWD is the first peer returned for this comparison set.